A first-in-human phase I/II study of GFH375, a highly selective and potent oral KRAS G12D inhibitor in patients with KRAS G12D mutant advanced solid tumors. This is an ASCO Meeting Abstract from the ...
Sure, this is a rat study, but the biomechanics are solid. Turns out, that critical shoulder angle is, critical after all.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results